跳至主要内容
临床试验/NL-OMON56751
NL-OMON56751招募中不适用

Radio-frequency sensing: non-invasive monitoring of heart failure progression - AIM-HF study

niversitair Medisch Centrum Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients planned for a right heart catheterization with invasive pressure
  • measurement
  • Patients that are screened for a left ventricular assist device or a heart
  • Patients that have recently received a heart transplant
  • Patients with NYHA class II-IV heart failure, preserved as well as reduced
  • ejection fraction
  • Patients with pulmonary hypertension
  • Patients with known (risk of) chemotherapy induced cardiac dysfunction
  • Patients with any cardiac arrhythmia
  • Patients with an implantable pulmonary artery pressure sensor
  • Cardiovascular patients on the intensive care unit or cardiac care unit
  • undergoing daily hemodynamic measurements

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Patients that have an active implant (cardiac implant such as CRT, ICD, LVAD,
  • or any other active implants such as insulin pump, cochlear implant or neural
  • stimulator) that cannot be switched to passive or sensing mode.
  • Patients is expected to die within 6 months from any nonrelated disease
  • Patient that are not physically able to undergo TTE, MRI and/or RFS
  • measurements at the time of inclusion

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验